• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

28.47 -2.03 (-6.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,255,187
Open 30.70
Bid (Size) 28.40 (1,000)
Ask (Size) 28.50 (200)
Prev. Close 30.50
Today's Range 28.21 - 30.90
52wk Range 25.28 - 46.48
Shares Outstanding 154,420,772
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TG Therapeutics TGTX Q3 2025 Earnings Transcript ↗
November 27, 2025
TG Therapeutics TGTX Q3 2025 Earnings Transcript 
Via The Motley Fool
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
November 11, 2025
 
Via Benzinga

Performance

YTD
-2.8%
-2.8%
1 Month
-7.0%
-7.0%
3 Month
-15.7%
-15.7%
6 Month
-23.2%
-23.2%
1 Year
-1.4%
-1.4%

More News

Read More
News headline image
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗
November 10, 2025
Via Investor's Business Daily
News headline image
Hussman Sells Off All 21,000 CHKP Shares Valued At $4.65 Million ↗
November 03, 2025
Via The Motley Fool
TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug ↗
November 03, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 3, 2025 ↗
November 03, 2025
Via Benzinga
News headline image
Earnings Preview For TG Therapeutics ↗
October 31, 2025
Via Benzinga
TG Therapeutics Board Authorizes New $100M Share Repurchase Program ↗
September 03, 2025
Via Stocktwits
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
November 03, 2025
Via Benzinga
News headline image
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗
November 03, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 4, 2025 ↗
August 04, 2025
Via Benzinga
News headline image
What's Next: TG Therapeutics's Earnings Preview ↗
August 01, 2025
Via Benzinga
News headline image
Highly Watched TG Therapeutics Smashes Profit Views — With A Caveat ↗
November 03, 2025
Via Investor's Business Daily
Topics Earnings
News headline image
Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗
October 16, 2025
Via Benzinga
News headline image
TG THERAPEUTICS INC (NASDAQ:TGTX) Shows High Growth Momentum and Technical Breakout Setup ↗
October 07, 2025
Via Chartmill
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
October 01, 2025
Via Benzinga
News headline image
TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback ↗
September 03, 2025
Via Benzinga
News headline image
TG Therapeutics Stock Tumbles 15% After Disappointing Q2, But Company Reaffirms Confidence In Multiple Sclerosis Drug ↗
August 04, 2025
Via Stocktwits
Topics Earnings
News headline image
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results ↗
August 04, 2025
Via Benzinga
News headline image
Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide ↗
August 04, 2025
Via Benzinga
News headline image
TG Therapeutics Q2 Revenue Up 91% ↗
August 04, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Top 3% Stock TG Therapeutics Crashed Despite Raising Its 2025 Outlook ↗
August 04, 2025
Via Investor's Business Daily
News headline image
Traders are paying attention to the gapping stocks in Monday's session. ↗
August 04, 2025
Via Chartmill
News headline image
TG Therapeutics Inc (NASDAQ:TGTX) Reports Mixed Q2 2025 Results, Raises Full-Year BRIUMVI Revenue Guidance ↗
August 04, 2025
Via Chartmill
News headline image
TG THERAPEUTICS INC (NASDAQ:TGTX) – A High Growth Momentum Stock with Strong Technical Setup ↗
July 17, 2025
Via Chartmill

Frequently Asked Questions

Is TG Therapeutics, Inc. - Common Stock publicly traded?
Yes, TG Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TG Therapeutics, Inc. - Common Stock trade on?
TG Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TG Therapeutics, Inc. - Common Stock?
The ticker symbol for TG Therapeutics, Inc. - Common Stock is TGTX on the Nasdaq Stock Market
What is the current price of TG Therapeutics, Inc. - Common Stock?
The current price of TG Therapeutics, Inc. - Common Stock is 28.47
When was TG Therapeutics, Inc. - Common Stock last traded?
The last trade of TG Therapeutics, Inc. - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of TG Therapeutics, Inc. - Common Stock?
The market capitalization of TG Therapeutics, Inc. - Common Stock is 4.40B
How many shares of TG Therapeutics, Inc. - Common Stock are outstanding?
TG Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap